Clinical Trials in San Antonio

Showing 3061-3080 of 12,572 trials

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

NCT06246786

This will be a single arm, non-randomized, pre-surgical clinical trial of women with newly diagnosed triple negative breast cancer with high g-H2Ax (gamma H2AX antibodies) comparing changes in biomarkers from a diagnostic core needle biopsy to surgical pathology specimen or repeat core needle biopsy.

Triple Negative Breast CancerDNA Damage Repair Deficiency

Virginia G. KaklamaniStarted Jul 2024

San Antonio, Texas, United States

Active Not RecruitingPhase 3< 1 mile

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

NCT04915755

This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast cancer (Independent of hormone receptor \[HR\] status, including HR positive \[+\] and TNBC) or tumor BRCA wild type (tBRCAwt) TNBC with molecular disease based on the presence of circulating tumor Deoxyribonucleic acid (ctDNA) following surgery or completion of adjuvant therapy.

Neoplasms, Breast

GlaxoSmithKline40 participantsStarted Jun 2021

Burbank, California, United States • Duarte, California, United States • Palo Alto, California, United States +195 more locations

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

Find Trials by Condition in San Antonio

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

9-ING-41 in Pediatric Patients With Refractory Malignancies.

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

A Study to Compare Nighttime Aligners to Daytime Aligners

Expanded Clinical Study of the Tendyne Mitral Valve System

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel